Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 236
Filter
1.
Peptides ; 152: 170775, 2022 06.
Article in English | MEDLINE | ID: mdl-35231551

ABSTRACT

Vascular aging is a complex and multifaceted process that provokes profound molecular, structural, and functional changes in the vasculature. Eventually, these profound aging alterations make arteries more prone to vascular disease, including hypertension, atherosclerosis and other arterial complications that impact the organism beyond the cardiovascular system and accelerate frailty. For these reasons, preventing or delaying the hallmarks of vascular aging is nowadays a major health goal, especially in our aged societies. In this context, angiotensin(Ang)-(1-7), a major player of the protective branch of the renin-angiotensin system, has gained relevance over recent years as growing knowledge on its anti-aging properties is being unveiled. Here, we briefly review the main actions of Ang-(1-7) against vascular aging. These include protection against vascular cell senescence, anti-inflammatory and antioxidant effects together with the induction of cytoprotective systems. Ang-(1-7) further ameliorates endothelial dysfunction, a hallmark of vascular aging and disease, attenuates fibrosis and calcification and promotes protective angiogenesis and repair. Although further research is needed to better understand the anti-aging properties of Ang-(1-7) on the vasculature, this heptapeptide arises as a promising pharmacological tool for preventing vascular aging and frailty.


Subject(s)
Frailty , Aged , Aging , Angiotensin I/metabolism , Angiotensin I/pharmacology , Angiotensin II/metabolism , Humans , Peptide Fragments/metabolism , Peptide Fragments/pharmacology , Renin-Angiotensin System
2.
Acta pediatr. esp ; 76(5/6): 77-82, mayo-jun. 2018. tab, graf
Article in Spanish | IBECS | ID: ibc-177402

ABSTRACT

Introducción: La detección precoz de la hipoacusia permite realizar un tratamiento temprano de los pacientes mejorando significativamente su pronóstico. Con este objetivo se implantó en la Comunidad Valencia el programa de cribado universal de la hipoacusia neonatal. Material y métodos: Se realizó un estudio de los resultados de dicho cribado desde su implantación en enero de 2002 hasta diciembre de 2014, es decir, durante 13 años consecutivos. Posteriormente se revisaron todos los casos que no superaron el cribado. Resultados: La cobertura del cribado alcanzó en pocos años a prácticamente el 100% de la población, con un total de recién nacidos cribados de 14.339. La tasa global de derivación a confirmación fue del 1%, y hubo un 0,7% de pérdidas. Se diagnosticaron 32 casos de hipoacusia neurosensorial (2,23/1.000 recién nacidos). Se estudiaron los casos que no superaron el cribado auditivo, y se halló una asociación entre diferentes variables, como los antecedentes familiares y la edad gestacional, con la presencia de hipoacusia neurosensorial bilateral. Conclusiones: El programa de cribado de la hipoacusia neonatal requiere unos años para su total universalización y cumplir de forma fiable las recomendaciones de la Comisión para la Detección Precoz de la Hipoacusia. Tras estudiar los casos que no superaron el cribado, se propone la edad gestacional como factor de riesgo para el desarrollo de hipoacusia. Asimismo, se considera que los neonatos con malformaciones craneofaciales se beneficiarían de ser remitidos directamente a una prueba de confirmación, así como de la realización de pruebas de imagen, por la alta probabilidad de presentar una patología malformativa asociada en el oído medio. Por otro lado, este ensayo permite recomendar la realización de un estudio cardiológico a los recién nacidos con diagnóstico de hipoacusia neurosensorial bilateral


Introduction: Early detection of hearing loss allows early treatment of these patients by significantly improving their prognosis. With this aim, the universal screening program for neonatal hearing loss was implemented in the Comunidad Valenciana. Material and methods: The results of this screening are studied, from its implementation in January 2002 to December 2014 (13 consecutive years). Subsequently, all the cases that did not pass the screening were reviewed. Results: The coverage of the screening reaches in a few years to practically 100% of the population, with 14339 of newborns being screened. The overall rate of referral to confirmation was 1% and there was 0.7% of losses. Thirty-two cases of neurosensory hearing loss were diagnosed (2.23/1000 newborns). We studied those cases that did not pass the auditory screening, finding an association between different variables such as family history of deafness and gestational age with the presence of bilateral sensorineural hearing loss. Conclusions: The neonatal hearing loss screening program requires a few years to be fully universalized and can reliably fulfill the recommendations of Comisión para la Detección Precoz de la Hipoacusia. After studying those cases that did not exceed the screening, gestational age is proposed as a risk factor for the development of hearing loss. Neonates with craniofacial malformations would also benefit from being referred directly to confirmatory test, as well as from the imaging test, due to the high probability of associated malformative pathology in the middle ear. On the other hand, this study allows the recommendation of a cardiological study to the newborns with diagnosis of bilateral sensorineural hearing loss


Subject(s)
Humans , Infant, Newborn , Hearing Loss, Sensorineural/diagnosis , Early Diagnosis , Neonatal Screening/methods , Gestational Age , Otoacoustic Emissions, Spontaneous
3.
J Nutr Health Aging ; 21(7): 825-829, 2017.
Article in English | MEDLINE | ID: mdl-28717813

ABSTRACT

OBJECTIVES: The European Working Group on Sarcopenia in Older People (EWGSOP) has proposed different methods and cut-off points for the three parameters that define sarcopenia: muscle mass, muscle strength and physical performance. Although this facilitates clinical practice, it limits comparability between studies and leads to wide differences in published prevalence rates. The aim of this study was to assess how changes in cut-off points for muscle mass, gait speed and grip strength affected sarcopenia prevalence according to EWGSOP criteria. METHODS: Cross-sectional analysis of elderly individuals recruited from outpatient clinics (n=298) and nursing homes (n=276). We measured muscle mass, grip strength and gait speed and assessed how changes in cut-off points changed sarcopenia prevalence in both populations. RESULTS: An increase from 5.45 kg/m2 to 6.68 kg/m2 in the muscle mass index for female outpatients and nursing-home residents increased sarcopenia prevalence from 4% to 23% and from 9% to 47%, respectively; for men, for an increase from 7.25 kg/m2 to 8.87 kg/m2, the corresponding increases were from 1% to 22% and from 6% to 41%, respectively. Changes in gait speed and grip strength had a limited impact on sarcopenia prevalence. CONCLUSION: The cut-off points used for muscle mass affect the reported prevalence rates for sarcopenia and, in turn, affect comparability between studies. The main factors influencing the magnitude of the change are muscle mass index distribution in the population and the absolute value of the cut-off points: the same difference between two references (e.g., 7.5 kg/m2 to 7.75 kg/m2 or 7.75 kg/m2 to 8 kg/m2) may produce different changes in prevalence. Changes in cut-off points for gait speed and grip strength had a limited impact on sarcopenia prevalence and on study comparability.


Subject(s)
Hand Strength , Muscle Strength , Sarcopenia/epidemiology , Walking Speed , Aged , Cross-Sectional Studies , Female , Geriatric Assessment , Homes for the Aged , Humans , Male , Nursing Homes , Prevalence
4.
Rev Neurol ; 63(s02): 1, 2016 Oct 03.
Article in Spanish | MEDLINE | ID: mdl-27699758

ABSTRACT

One of the main objectives of the Spanish Sleep Society is to promote healthy sleep in both the general population and in health professionals. This document aims to conduct a review of the current scientific literature on sleep habits that can serve as the basis on which to establish a set of general recommendations, regarding healthy sleep, for use by the general population in Spain as well as to identify the main challenges faced by research into sleep habits. The document has been developed by a multidisciplinary team made up of members of the Spanish Sleep Society who are experts in paediatric sleep medicine, clinical neurophysiology, pulmonology, neurology, chronobiology, physiology and psychology. The existing scientific literature dealing with sleep habits in the general population was reviewed, and the following aspects were addressed: the current state of sleep habits in the Spanish population; a generic review of the optimum number of hours of sleep; the impact of the environmental setting (noise, temperature, illumination, etc.), hours of sleep, diet and sport, together with several specific sections for children and teenagers, shift-workers and drivers of different vehicles. The conclusions from all the aspects addressed in this document have resulted in a set of final general recommendations that will serve as a guide for the general population and health professionals. Likewise, the principal environmental challenges and future lines of research are also discussed.


Subject(s)
Habits , Sleep , Adolescent , Child , Guidelines as Topic , Humans , Spain
5.
PLoS One ; 11(7): e0158489, 2016.
Article in English | MEDLINE | ID: mdl-27441722

ABSTRACT

AIM: To evaluate the performance of the Finnish Diabetes Risk Score (FINDRISC) and a simplified FINDRISC score (MADRISC) in screening for undiagnosed type 2 diabetes mellitus (UT2DM) and dysglycaemia. METHODS: A population-based, cross-sectional, descriptive study was carried out with participants with UT2DM, ranged between 45-74 years and lived in two districts in the north of metropolitan Madrid (Spain). The FINDRISC and MADRISC scores were evaluated using the area under the receiver operating characteristic curve method (ROC-AUC). Four different gold standards were used for UT2DM and any dysglycaemia, as follows: fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), HbA1c, and OGTT or HbA1c. Dysglycaemia and UT2DM were defined according to American Diabetes Association criteria. RESULTS: The study population comprised 1,426 participants (832 females and 594 males) with a mean age of 62 years (SD = 6.1). When HbA1c or OGTT criteria were used, the prevalence of UT2DM was 7.4% (10.4% in men and 5.2% in women; p<0.01) and the FINDRISC ROC-AUC for UT2DM was 0.72 (95% CI, 0.69-0.74). The optimal cut-off point was ≥13 (sensitivity = 63.8%, specificity = 65.1%). The ROC-AUC of MADRISC was 0.76 (95% CI, 0.72-0.81) with ≥13 as the optimal cut-off point (sensitivity = 84.8%, specificity = 54.6%). FINDRISC score ≥12 for detecting any dysglycaemia offered the best cut-off point when HbA1c alone or OGTT and HbA1c were the criteria used. CONCLUSIONS: FINDRISC proved to be a useful instrument in screening for dysglycaemia and UT2DM. In the screening of UT2DM, the simplified MADRISC performed as well as FINDRISC.


Subject(s)
Diabetes Mellitus, Type 2/diagnosis , Hyperglycemia/diagnosis , Mass Screening , Residence Characteristics , Adult , Aged , Cross-Sectional Studies , Diabetes Mellitus, Type 2/complications , Female , Finland , Humans , Hyperglycemia/complications , Male , Middle Aged , Prevalence , ROC Curve , Risk Factors , Spain , Surveys and Questionnaires
6.
Hipertens. riesgo vasc ; 33(1): 21-27, ene.-mar. 2016. tab, ilus
Article in Spanish | IBECS | ID: ibc-149330

ABSTRACT

Introducción: Las vesículas extracelulares (EV) son liberadas al torrente circulatorio por determinados tipos celulares a consecuencia de procesos de transporte, activación o muerte celular. El recuento de EV circulantes de origen plaquetario y endotelial ha demostrado tener un importante papel como biomarcador de riesgo cardiovascular. Por lo tanto, el proteoma de estas EV podría reflejar los procesos celulares subyacentes en pacientes con hipertensión arterial y albuminuria. Material y métodos: El contenido proteico de las EV circulantes se ha analizado mediante cromatografía líquida acoplada a espectrometría de masas. Las EV han sido aisladas mediante un protocolo de ultracentrifugación optimizado para evitar la contaminación de proteínas del plasma. La pureza de la fracción aislada ha sido verificada mediante microscopia electrónica y confocal, y por citometría de flujo. Resultados: En este estudio mostramos un método de gran rendimiento y pureza para obtener extractos proteicos de EV circulantes de pacientes hipertensos con/sin albuminuria para análisis proteómico. Además, aportamos el proteoma de referencia de EV de estos pacientes, compuesto por 2.463 proteínas, y demostramos que las proteínas transportadas por estas vesículas están relacionadas con procesos cruciales involucrados en el riesgo cardiovascular asociado. Conclusión: El proteoma de las EV circulantes constituye una interesante fuente de indicadores para la evaluación de procesos relacionados con el riesgo cardiovascular en pacientes hipertensos con bloqueo del sistema renina-angiotensina


Introduction: Extracellular vesicles (EVs) are released to the bloodstream by certain cell types due to transport, activation and cell death processes. Blood count of EVs from platelet and endothelial origin has been proved to be a cardiovascular risk biomarker. Thus, EVs proteome might reflect the underlying cellular processes in hypertensive patients with albuminuria. Material and methods: Protein content of circulating EVs was analyzed by liquid chromatography coupled to mass spectrometry. EVs were isolated by an ultracentrifugation protocol optimized in order to avoid contamination by blood plasma proteins. Purity of the isolated fraction was verified by electronic and confocal microscopy, and by flow cytometry. Results: We hereby show a method to isolate circulating EVs from hypertensive patients with/without albuminuria with high yield and purity. Besides, we provide a reference proteome of the EVs of these patients, composed of 2,463 proteins, and prove that the proteins carried by these vesicles are associated with crucial processes involved in the inherent cardiovascular risk. Conclusion: The proteome of circulating EVs is an interesting source of indicators in the evaluation of cardiovascular risk in hypertensive patients with renin-angiotensin system blockage


Subject(s)
Humans , Cardiovascular Diseases/epidemiology , Proteome/physiology , Albuminuria/physiopathology , Hypertension/physiopathology , Risk Factors , Renin-Angiotensin System/physiology , Extracellular Matrix Proteins/pharmacokinetics
7.
Hipertens Riesgo Vasc ; 33(1): 21-7, 2016.
Article in Spanish | MEDLINE | ID: mdl-26826536

ABSTRACT

INTRODUCTION: Extracellular vesicles (EVs) are released to the bloodstream by certain cell types due to transport, activation and cell death processes. Blood count of EVs from platelet and endothelial origin has been proved to be a cardiovascular risk biomarker. Thus, EVs proteome might reflect the underlying cellular processes in hypertensive patients with albuminuria. MATERIAL AND METHODS: Protein content of circulating EVs was analyzed by liquid chromatography coupled to mass spectrometry. EVs were isolated by an ultracentrifugation protocol optimized in order to avoid contamination by blood plasma proteins. Purity of the isolated fraction was verified by electronic and confocal microscopy, and by flow cytometry. RESULTS: We hereby show a method to isolate circulating EVs from hypertensive patients with/without albuminuria with high yield and purity. Besides, we provide a reference proteome of the EVs of these patients, composed of 2,463 proteins, and prove that the proteins carried by these vesicles are associated with crucial processes involved in the inherent cardiovascular risk. CONCLUSION: The proteome of circulating EVs is an interesting source of indicators in the evaluation of cardiovascular risk in hypertensive patients with renin-angiotensin system blockage.


Subject(s)
Cardiovascular Diseases/epidemiology , Extracellular Vesicles , Proteome , Renin-Angiotensin System , Blood Platelets , Blood Proteins , Chromatography, Liquid , Flow Cytometry , Humans , Risk Factors , Secretory Vesicles , Transport Vesicles
8.
Biosystems ; 129: 25-35, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25625871

ABSTRACT

Evolutionary dynamics has been classically studied for homogeneous populations, but now there is a growing interest in the non-homogeneous case. One of the most important models has been proposed in Lieberman et al. (2005), adapting to a weighted directed graph the process described in Moran (1958). The Markov chain associated with the graph can be modified by erasing all non-trivial loops in its state space, obtaining the so-called Embedded Markov chain (EMC). The fixation probability remains unchanged, but the expected time to absorption (fixation or extinction) is reduced. In this paper, we shall use this idea to compute asymptotically the average fixation probability for complete bipartite graphs K(n,m). To this end, we firstly review some recent results on evolutionary dynamics on graphs trying to clarify some points. We also revisit the 'Star Theorem' proved in Lieberman et al. (2005) for the star graphs K(1,m). Theoretically, EMC techniques allow fast computation of the fixation probability, but in practice this is not always true. Thus, in the last part of the paper, we compare this algorithm with the standard Monte Carlo method for some kind of complex networks.


Subject(s)
Biological Evolution , Models, Biological , Models, Statistical , Markov Chains , Monte Carlo Method , Probability
11.
Vet Immunol Immunopathol ; 152(3-4): 277-88, 2013 Apr 15.
Article in English | MEDLINE | ID: mdl-23375019

ABSTRACT

A single broadly reactive standard ELISA is commonly applied to control small ruminant lentivirus (SRLV) spread, but type specific ELISA strategies are gaining interest in areas with highly prevalent and heterogeneous SRLV infections. Short (15-residue) synthetic peptides (n=60) were designed in this study using deduced amino acid sequence profiles of SRLV circulating in sheep from North Central Spain and SRLV described previously. The corresponding ELISAs and two standard ELISAs were employed to analyze sera from sheep flocks either controlled or infected with different SRLV genotypes. Two outbreaks, showing SRLV-induced arthritis (genotype B2) and encephalitis (genotype A), were represented among the infected flocks. The ELISA results revealed that none of the assays detected all the infected animals in the global population analyzed, the assay performance varying according to the genetic type of the strain circulating in the area and the test antigen. Five of the six highly reactive (57-62%) single peptide ELISAs were further assessed, revealing that the ELISA based on peptide 98M (type A ENV-SU5, consensus from the neurological outbreak) detected positives in the majority of the type-A specific sera tested (Se: 86%; Sp: 98%) and not in the arthritic type B outbreak. ENV-TM ELISAs based on peptides 126M1 (Se: 82%; Sp: 95%) and 126M2 0,65 0.77 (Se: 68%; Sp: 88%) detected preferentially caprine arthritis encephalitis (CAEV, type B) and visna/maedi (VMV, type A) virus infections respectively, which may help to perform a preliminary CAEV vs. VMV-like typing of the flock. The use of particular peptide ELISAs and standard tests individually or combined may be useful in the different areas under study, to determine disease progression, diagnose/type infection and prevent its spread.


Subject(s)
Enzyme-Linked Immunosorbent Assay/veterinary , Lentivirus Infections/veterinary , Sheep Diseases/diagnosis , Amino Acid Sequence , Animals , Antibodies, Viral/blood , Antigens, Viral/genetics , Arthritis-Encephalitis Virus, Caprine/genetics , Arthritis-Encephalitis Virus, Caprine/immunology , Disease Outbreaks/veterinary , Enzyme-Linked Immunosorbent Assay/methods , Enzyme-Linked Immunosorbent Assay/statistics & numerical data , Genes, gag , Goats , Lentivirus Infections/diagnosis , Lentivirus Infections/epidemiology , Molecular Sequence Data , Phylogeny , Pneumonia, Progressive Interstitial, of Sheep/diagnosis , Pneumonia, Progressive Interstitial, of Sheep/epidemiology , Pneumonia, Progressive Interstitial, of Sheep/immunology , Sheep , Sheep Diseases/epidemiology , Sheep Diseases/immunology , Sheep, Domestic , Spain/epidemiology , Viral Proteins/genetics , Viral Proteins/immunology , Visna/diagnosis , Visna/epidemiology , Visna/immunology , Visna-maedi virus/genetics , Visna-maedi virus/immunology
12.
J Sleep Res ; 21(4): 357-68, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22133127

ABSTRACT

The present paper describes standardized procedures within clinical sleep medicine. As such, it is a continuation of the previously published European guidelines for the accreditation of sleep medicine centres and European guidelines for the certification of professionals in sleep medicine, aimed at creating standards of practice in European sleep medicine. It is also part of a broader action plan of the European Sleep Research Society, including the process of accreditation of sleep medicine centres and certification of sleep medicine experts, as well as publishing the Catalogue of Knowledge and Skills for sleep medicine experts (physicians, non-medical health care providers, nurses and technologists), which will be a basis for the development of relevant educational curricula. In the current paper, the standard operational procedures sleep medicine centres regarding the diagnostic and therapeutic management of patients evaluated at sleep medicine centres, accredited according to the European Guidelines, are based primarily on prevailing evidence-based medicine principles. In addition, parts of the standard operational procedures are based on a formalized consensus procedure applied by a group of Sleep Medicine Experts from the European National Sleep Societies. The final recommendations for standard operational procedures are categorized either as 'standard practice', 'procedure that could be useful', 'procedure that is not useful' or 'procedure with insufficient information available'. Standard operational procedures described here include both subjective and objective testing, as well as recommendations for follow-up visits and for ensuring patients' safety in sleep medicine. The overall goal of the actual standard operational procedures is to further develop excellence in the practice and quality assurance of sleep medicine in Europe.


Subject(s)
Sleep Medicine Specialty/standards , Accreditation/standards , Actigraphy/standards , Adult , Certification/standards , Europe , Humans , Patient Safety , Polysomnography/standards , Practice Guidelines as Topic , Sleep Medicine Specialty/education , Sleep Wake Disorders/diagnosis , Sleep Wake Disorders/therapy , Societies, Medical/standards , Workload/standards
13.
Scand J Immunol ; 69(2): 80-9, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19144076

ABSTRACT

The development of immunization strategies to induce strong and multiepitopic T-cell responses against tumour antigens is needed for anti-tumour immunotherapy. However, a common finding after immunization with complex antigens is the preferential induction of immune responses against immunodominant epitopes. In this study, with the aim of inducing multiepitopic responses against several common tumour antigens, we have designed a minigene construct encoding four human leucocyte antigen (HLA)-A2-restricted epitopes belonging to tumour antigens CEA (CEA-691 and CEA-571), MAGE2 (MAGE2-157) and MAGE3 (MAGE3-112), as well as the universal PADRE epitope recognized by T helper lymphocytes. To optimize the activation of immune responses against these epitopes, we have used different antigen formats (short peptides encompassing individual epitopes and DNA plasmids or adenoviral constructs expressing the minigene) in single or combined immunization schedules. A single immunization with either DNA plasmid or recombinant adenovirus induced a monospecific immune response against the immunodominant epitope CEA-571, whereas immunization with the peptide pool induced responses against all epitopes. Combination of peptide priming followed by a boost with the plasmid and the recombinant adenovirus expressing the minigene induced stronger, multi-specific and long-lasting immune responses, overcoming the immunodominance imposed by the main T-cell epitope. Moreover, these combined immunization strategies were able to induce responses that were able to recognize Mel624 HLA-A2+ tumour cells expressing MAGE2. These results suggest that heterologous immunization strategies combining peptides and DNA or recombinant adenoviruses can be useful to broaden the specificity and enhance the efficacy of subunit vaccines.


Subject(s)
Antigens, Neoplasm/immunology , Cancer Vaccines/immunology , Epitopes, T-Lymphocyte , Peptides/immunology , Vaccines, DNA/immunology , Vaccines, Synthetic/immunology , Adenoviridae/genetics , Animals , Carcinoembryonic Antigen/immunology , HLA-A2 Antigen/immunology , Humans , Immunization , Mice , Neoplasm Proteins/immunology , Plasmids , T-Lymphocytes, Cytotoxic/immunology
14.
J Viral Hepat ; 15(11): 782-9, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18637068

ABSTRACT

Dendritic cells (DC) transfected with an adenovirus encoding hepatitis C virus (HCV) NS3 protein (AdNS3) induce potent antiviral immune responses when used to immunize mice. However, in HCV infected patients, controversial results have been reported regarding the functional properties of monocyte-derived DC (MoDC), a cell population commonly used in DC vaccination protocols. Thus, with the aim of future vaccination studies we decided to characterize MoDC from HCV patients transfected with AdNS3 and stimulated with the TLR3 ligand poly(I:C). Phenotypic and functional properties of these cells were compared with those from MoDC obtained from uninfected individuals. PCR analysis showed that HCV RNA was negative in MoDC from patients after the culture period. Also, phenotypic analysis of these cells showed lower expression of CD80, CD86, and CD40, but similar expression of HLA-DR molecules as compared to MoDC from uninfected individuals. Functional assays of MoDC obtained from patients and controls showed a similar ability to activate allogeneic lymphocytes or to produce IL-12 and IL-10, although lower IFN-alpha levels were produced by cells from HCV patients after poly(I:C) stimulation. Moreover, both groups of MoDC induced similar profiles of IFN-gamma and IL-5 after stimulation of allogeneic T-cells. Finally, migration assays did not reveal any difference in their ability to respond to CCL21 chemokine. In conclusion, MoDC from HCV patients are functional after transduction with AdNS3 and stimulation with poly(I:C). These findings suggest that these cells may be useful for therapeutic vaccination in chronic HCV infection.


Subject(s)
Dendritic Cells/immunology , Hepacivirus/immunology , Hepatitis C/immunology , Immunologic Factors/pharmacology , Poly I-C/pharmacology , Toll-Like Receptor 3/agonists , Viral Nonstructural Proteins/immunology , Adenoviridae/genetics , Adult , Aged , Antigens, CD/analysis , Cytokines/metabolism , Dendritic Cells/chemistry , Female , Genetic Vectors , HLA-DR Antigens/analysis , Humans , Male , Middle Aged , Transduction, Genetic , Viral Nonstructural Proteins/genetics
15.
Biomark Insights ; 3: 101-113, 2008 Mar 12.
Article in English | MEDLINE | ID: mdl-19578499

ABSTRACT

SUMMARY: Biomarkers provide a powerful approach to understanding the spectrum of cardiovascular diseases. They have application in screening, diagnostic, prognostication, prediction of recurrences and monitoring of therapy. The "omics" tool are becoming very useful in the development of new biomarkers in cardiovascular diseases. Among them, proteomics is especially fitted to look for new proteins in health and disease and is playing a significant role in the development of new diagnostic tools in cardiovascular diagnosis and prognosis. This review provides an overview of progress in applying proteomics to atherosclerosis. First, we describe novel proteins identified analysing atherosclerotic plaques directly. Careful analysis of proteins within the atherosclerotic vascular tissue can provide a repertoire of proteins involved in vascular remodelling and atherogenesis. Second, we discuss recent data concerning proteins secreted by atherosclerotic plaques. The definition of the atheroma plaque secretome resides in that proteins secreted by arteries can be very good candidates of novel biomarkers. Finally we describe proteins that have been differentially expressed (versus controls) by individual cells which constitute atheroma plaques (endothelial cells, vascular smooth muscle cells, macrophages and foam cells) as well as by circulating cells (monocytes, platelets) or novel biomarkers present in plasma.

16.
Vascul Pharmacol ; 47(2-3): 83-9, 2007.
Article in English | MEDLINE | ID: mdl-17581795

ABSTRACT

BACKGROUND: The protective effect of acetylsalicylic acid (aspirin) against cardiovascular events is known to be weaker in women than in men. The present study was designed to test whether this effect of aspirin differed between sexes in an experimental model of diabetes with retinal ischemia. METHODS: We compared nondiabetic rats and rats after 1, 2 and 3 months of diabetes that were given 2 mg/kg/day p.o. of aspirin from the first day of diabetes. The variables recorded were platelet aggregation, production of thromboxane B(2) (TxB(2)), 6-keto-prostaglandin F(1alpha) and aortic nitric oxide, and the percentage of the retinal surface occupied by horseradish peroxidase (HRP)-permeable vessels. RESULTS: In female rats made diabetic, TxB(2) synthesis was more markedly reduced, and the percentage of HRP-permeable retinal vessels was less markedly reduced, than in their male counterparts. The response to aspirin treatment was weaker in female than in male diabetic rats in terms of inhibition of TxB(2) synthesis, increased nitric oxide production, and prevention of the increase in the percentage of retinal surface covered by HRP-permeable vessels. CONCLUSION: Aspirin was less effective in preventing retinal ischemia in experimental diabetes in female than in male rats.


Subject(s)
Aspirin/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Ischemia/drug therapy , Platelet Aggregation Inhibitors/pharmacology , Retinal Vessels/drug effects , Animals , Diabetes Mellitus, Experimental/complications , Diabetic Retinopathy/prevention & control , Female , Male , Nitric Oxide/biosynthesis , Platelet Aggregation/drug effects , Prostaglandins/biosynthesis , Rats , Rats, Wistar , Sex Factors , Streptozocin , Thromboxane B2/biosynthesis
17.
Life Sci ; 79(15): 1405-12, 2006 Sep 05.
Article in English | MEDLINE | ID: mdl-16737715

ABSTRACT

We analyze the effect of the combination of acetylsalicylic acid (2 mg/kg/day p.o.) and alpha-tocopherol (25 mg/kg/day p.o.) in a type-1-like experimental model of diabetes mellitus on platelet factors, endothelial antithrombotic factors and tissue oxidative stress. In diabetic rats, the combination of drugs had a greater inhibitory effect on platelet aggregation than in untreated control animals with diabetes (88.87%). The combination of drugs had little effect on the inhibition of thromboxane production (-90.81%) in comparison to acetylsalicylic acid alone (-84.66%), potentiated prostacyclin production (+162%) in comparison to alpha-tocopherol alone (+30.55%), and potentiated nitric oxide production (+241%) in comparison to either drug alone (acetylsalicylic acid +125%, alpha-tocopherol +142%). The combination of the two drugs improved the thromboxane/prostacyclin balance (0.145+/-0.009) in comparison to untreated diabetic animals (4.221+/-0.264) and in untreated healthy animals (0.651+/-0.045). It did not potentiate the antioxidant effect of either drug alone, but did increase tissue concentrations of reduced glutathione, especially in vascular tissue (+90.09% in comparison to untreated animals). In conclusion, in the experimental model of diabetes tested here, the combination of acetylsalicylic acid and alpha-tocopherol led to beneficial changes that can help protect tissues from thrombotic and ischemic phenomena.


Subject(s)
Antioxidants/pharmacology , Aspirin/pharmacology , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/physiopathology , Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 1/physiopathology , Platelet Aggregation Inhibitors/pharmacology , alpha-Tocopherol/pharmacology , Animals , Antioxidants/administration & dosage , Aspirin/administration & dosage , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Type 1/blood , Epoprostenol/metabolism , Male , Oxidative Stress/drug effects , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/administration & dosage , Rats , Rats, Wistar , Thromboxanes/metabolism , alpha-Tocopherol/administration & dosage
18.
Diabetes Metab Res Rev ; 22(5): 390-400, 2006.
Article in English | MEDLINE | ID: mdl-16705623

ABSTRACT

BACKGROUND: The aim of this study was to determine whether the brain tissue of type 1 diabetic animals is more susceptible to damage by hypoxia reoxygenation than healthy animals. METHODS: This study used rats with diabetes of 1, 2 and 3 months (N = 15 rats/group). Brain slices were subjected to hypoxia and reoxygenation for 180 min in vitro. We measured oxidative stress (lipid peroxidation, glutathione concentration and enzyme activities related to glutathione), concentration of prostaglandin E(2) (PGE(2)) and nitric oxide (NO) pathway (nitrite + nitrate, activities of constitutive (cNOS) and inducible (iNOS) nitric oxide synthase). As a parameter of cell death we measured the efflux of lactate dehydrogenase (LDH). RESULTS: After reoxygenation LDH activity increased in comparison to nondiabetic animals by 40, 40.6 and 68.9% in animals with diabetes of 1, 2 and 3 months duration, respectively. These changes were accompanied by greater increases in lipid peroxides (25.4, 93.7 and 92.8%). PGE(2) accumulated in significantly larger amounts in diabetic animals (62.5, 85.5 and 114%), and nitrite + nitrate accumulation was significantly greater in rats with diabetes of 2 (40.2%) and 3 months duration (24.0%). iNOS activity increased significantly in all the groups of diabetic animals, with the largest increases in rats with diabetes of 2 (18.6%) and 3 months duration (21.1%). CONCLUSIONS: The biochemical pathways involved in oxidative stress and neuronal death are more sensitive to hypoxia reoxygenation in type 1-like diabetic, as compared to normal, rats.


Subject(s)
Brain/physiopathology , Diabetes Mellitus, Experimental/physiopathology , Animals , Hypoxia , In Vitro Techniques , L-Lactate Dehydrogenase/analysis , Nitrates/metabolism , Nitrites/metabolism , Oxygen Consumption , Rats , Thiobarbituric Acid Reactive Substances/analysis
19.
Neurosci Lett ; 400(3): 252-7, 2006 Jun 12.
Article in English | MEDLINE | ID: mdl-16545519

ABSTRACT

Diabetes mellitus is a risk factor for cerebrovascular ischemic disease. Aspirin (acetylsalicylic acid) is the most widely used drug for the secondary prevention of thrombotic phenomena. It has been also recently demonstrated that alpha-tocopherol influenced in vitro the antiplatelet effect of aspirin. The aim of the present study is to evaluate the effects aspirin plus alpha-tocopherol on cerebral oxidative stress, prostaglandin production and the nitric oxide pathway in a model of hypoxia-reoxygenation in rat brain slices. Our results show an imbalance in brain oxidative status (reflected mainly as the increase in lipid peroxides) as a result of diabetes itself rather than a failure of the glutathione-based antioxidant system. Moreover, our results also show a higher concentration of prostaglandins in the brain of diabetic animals and a higher nitric oxide concentration, mainly through a high iNOS activity. After 180 min of post-hypoxia reoxygenation, LDH activity was 40.6% higher in animals with diabetes, in comparison to non-diabetic animals. The increase of the LDH efflux observed in non-treated rats was reduced by 31.2% with aspirin, by 34.7% with alpha-tocopherol and by 69.8% with the association aspirin-alpha-tocopherol. The accumulation of prostaglandin E2 observed in diabetic non-treated rats was reduced statistically after the treatment with aspirin (34.2% inhibition), alpha-tocopherol (19.3% inhibition) or the association aspirin-alpha-tocopherol (54.4% inhibition). Nitric oxide production after 180 min reoxygenation was significantly reduced in aspirin (36.4%), alpha-tocopherol (22.7%) and aspirin-alpha-tocopherol (77.8%) treated rats with respect to diabetic non-treated animals; this was related mainly with a reduction in iNOS activity. The association between aspirin and alpha tocopherol could protects against brain ischemic-reperfusion damage with a better profile than aspirin alone.


Subject(s)
Aspirin/administration & dosage , Brain Ischemia/metabolism , Brain Ischemia/prevention & control , Diabetes Mellitus, Type 1/metabolism , Reperfusion Injury/metabolism , Reperfusion Injury/prevention & control , alpha-Tocopherol/administration & dosage , Animals , Antioxidants/administration & dosage , Brain Ischemia/complications , Brain Ischemia/diagnosis , Cells, Cultured , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/diagnosis , Diabetes Mellitus, Type 1/drug therapy , Drug Combinations , Male , Neuroprotective Agents/administration & dosage , Platelet Aggregation Inhibitors/administration & dosage , Rats , Rats, Wistar , Reperfusion Injury/complications , Reperfusion Injury/diagnosis , Treatment Outcome
20.
J Viral Hepat ; 13(1): 47-55, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16364082

ABSTRACT

Successful clearance of hepatitis C virus (HCV) infection has been associated with strong cellular immune responses against viral antigens. However, although the magnitude of these responses is clearly important for viral eradication, more studies are needed to unravel the fine specificity of the protective anti-HCV immunity in infected patients. This was the aim of the present study. Overlapping peptides spanning the sequence of HCV E2 and NS4a proteins were used to stimulate T cells from patients with chronic hepatitis C divided into three groups: naïve patients, patients who exhibited sustained response to interferon (IFN)-alpha therapy and patients who failed to respond to the treatment. Interleukin-2 production by stimulated cells was measured in each case. Patients with sustained response to therapy had stronger responses to E2 peptides than nonresponders, whereas naïve patients demonstrated intermediate reactivity. In the case of NS4a, responses against peptides where similar in all groups of patients. Analysis of the peptides recognized by T cells showed that responses were broad and heterogeneous, and some immunodominant epitopes, preferentially recognized by patients exhibiting sustained response to treatment, were found. These results confirm the role of cellular immune responses in viral clearance, and stress the importance of immunodominant regions within HCV antigens. These viral sequences may represent valuable immunogens for preparation of therapeutic or prophylactic vaccines.


Subject(s)
Hepacivirus/immunology , Hepatitis C/immunology , T-Lymphocytes/immunology , Viral Envelope Proteins/immunology , Viral Nonstructural Proteins/immunology , Adult , Aged , Amino Acid Sequence , Female , HLA-DR Antigens/genetics , HLA-DR Antigens/immunology , Hepacivirus/genetics , Hepatitis C/virology , Humans , Immunodominant Epitopes/immunology , Interleukin-2/analysis , Male , Middle Aged , Molecular Sequence Data , Peptide Fragments/immunology , Peptide Fragments/pharmacology , RNA, Viral/chemistry , RNA, Viral/genetics , T-Lymphocytes/drug effects , T-Lymphocytes/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...